Moreover, interfering the expression of either ATG5 or Beclin1 with siRNA in CRC cells significantly restored the turnover of LC3 and accumulation of LC3 puncta after OXI treatment (Fig. 3F and Fig. S2B-E). The gene discussed is ATG5; the disease is colorectal carcinoma.